Pune-based Gennova to use SII's Covishield vaccine as the comparator

To assess the immunogenicity of the mRNA vaccine, Gennova will have to use Covishield — an existing vaccine — as a comparator, as the regulator has disallowed use of a placebo for the trials.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gVIBXt
via IFTTT